NO20081075L - Macrocykliske inhibitorer av hepatitt C virus - Google Patents

Macrocykliske inhibitorer av hepatitt C virus

Info

Publication number: NO20081075L
Authority: NO; Norway
Prior art keywords: alkylene; alkyl; carbocyclyl; hydrogen; heterocyclyl
Prior art date: 2005-07-29

Application number

NO20081075A

Other languages

English (en)

Norwegian (no)

Inventor

Herman Augustinus De Kock

Hans Wallberg

Pierre Jean-Marie Raboisson

Kenneth Alan Simmen

Lili Hu

Karl Magnus Nilsson

Bengt Bertil Samuelsson

Asa Annicka Kristina Rosenquist

Anna Karin Gertrud Linnea Belfrage

Mats Stefan Lindstrom

Pia Cecilia Kahnberg

Karin Charlotta Lindquist

Horst Juergen Wahling

Sven Christer Sahlberg

Bjorn Olof Classon

Original Assignee

Tibotec Pharm Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-07-29

Filing date

2008-02-29

Publication date

2008-04-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37708968&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20081075(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-02-29 Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd

2008-04-25 Publication of NO20081075L publication Critical patent/NO20081075L/no

Links

241000711549 Hepacivirus C Species 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
229910052739 hydrogen Inorganic materials 0.000 abstract 3
239000001257 hydrogen Substances 0.000 abstract 3
125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 3
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 abstract 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
206010057199 Flaviviral infections Diseases 0.000 abstract 1
150000001204 N-oxides Chemical class 0.000 abstract 1
125000001246 bromo group Chemical group Br* 0.000 abstract 1
229910052799 carbon Inorganic materials 0.000 abstract 1
125000001309 chloro group Chemical group Cl* 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
125000004663 dialkyl amino group Chemical group 0.000 abstract 1
125000004473 dialkylaminocarbonyl group Chemical group 0.000 abstract 1
125000001153 fluoro group Chemical group F* 0.000 abstract 1
-1 haloC 1 -C 6 alkyl Chemical group 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
- C07D245/04—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Plural Heterocyclic Compounds (AREA)

NO20081075A 2005-07-29 2008-02-29 Macrocykliske inhibitorer av hepatitt C virus NO20081075L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP05107057		2005-07-29
EP06113097		2006-04-25
PCT/EP2006/064822 WO2007014927A2 (en)	2005-07-29	2006-07-28	Macrocyclic inhibitors of hepatitis c virus

Publications (1)

Publication Number	Publication Date
NO20081075L true NO20081075L (no)	2008-04-25

Family

ID=37708968

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20081075A NO20081075L (no)	2005-07-29	2008-02-29	Macrocykliske inhibitorer av hepatitt C virus

Country Status (31)

Country	Link
US (1)	US7659245B2 (de)
EP (1)	EP1912981B1 (de)
JP (1)	JP5230418B2 (de)
KR (1)	KR101083631B1 (de)
AP (1)	AP2585A (de)
AR (1)	AR057702A1 (de)
AT (1)	ATE455775T1 (de)
AU (1)	AU2006274866B2 (de)
BR (1)	BRPI0614153A2 (de)
CA (1)	CA2617103C (de)
CY (1)	CY1110008T1 (de)
DE (1)	DE602006011905D1 (de)
DK (1)	DK1912981T3 (de)
EA (1)	EA014188B1 (de)
ES (1)	ES2339702T3 (de)
GT (1)	GT200600343A (de)
HR (1)	HRP20100209T1 (de)
IL (1)	IL188320A (de)
ME (1)	ME01454B (de)
MY (1)	MY151026A (de)
NO (1)	NO20081075L (de)
NZ (1)	NZ564540A (de)
PE (1)	PE20070343A1 (de)
PL (1)	PL1912981T3 (de)
PT (1)	PT1912981E (de)
RS (1)	RS51227B (de)
SI (1)	SI1912981T1 (de)
SV (1)	SV2008002641A (de)
TW (1)	TWI387597B (de)
UY (1)	UY29704A1 (de)
WO (1)	WO2007014927A2 (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY140680A (en)	2002-05-20	2010-01-15	Bristol Myers Squibb Co	Hepatitis c virus inhibitors
ES2336009T3 (es)	2004-01-30	2010-04-07	Medivir Ab	Inhibidores de la ns-3 serina proteasa del vhc.
PE20070211A1 (es) *	2005-07-29	2007-05-12	Medivir Ab	Compuestos macrociclicos como inhibidores del virus de hepatitis c
BRPI0614637A2 (pt)	2005-07-29	2011-04-12	Tibotec Pharm Ltd	inibidores macrocìclicos do vìrus da hepatite c
JO2768B1 (en) *	2005-07-29	2014-03-15	تيبوتيك فارماسيوتيكالز ليمتد	Large cyclic inhibitors of hepatitis C virus
RU2436787C2 (ru)	2005-07-29	2011-12-20	Тиботек Фармасьютикалз Лтд.	Макроциклические ингибиторы вируса гепатита с
EA200801050A1 (ru)	2005-10-11	2008-12-30	Интермьюн, Инк.	Соединения и способы ингибирования репликации вирусного гепатита с
US7741281B2 (en)	2005-11-03	2010-06-22	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
RU2008152171A (ru)	2006-07-05	2010-08-10	Интермьюн, Инк. (Us)	Новые ингибиторы вирусной репликации гепатита с
WO2008008776A2 (en)	2006-07-11	2008-01-17	Bristol-Myers Squibb Company	Hepatitis c virus inhibitors
ES2448494T3 (es)	2006-07-13	2014-03-14	Achillion Pharmaceuticals, Inc.	Péptidos de 4-amino-4-oxobutanoilo en calidad de inhibidores de la replicación viral
US8343477B2 (en)	2006-11-01	2013-01-01	Bristol-Myers Squibb Company	Inhibitors of hepatitis C virus
US7772180B2 (en)	2006-11-09	2010-08-10	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US7888464B2 (en)	2006-11-16	2011-02-15	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US7763584B2 (en)	2006-11-16	2010-07-27	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US8003604B2 (en)	2006-11-16	2011-08-23	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
WO2008059046A1 (en) *	2006-11-17	2008-05-22	Tibotec Pharmaceuticals Ltd.	Macrocyclic inhibitors of hepatitis c virus
RU2483067C2 (ru) *	2007-02-01	2013-05-27	Тиботек Фармасьютикалз Лтд.	Способы и промежуточные продукты для получения макроциклического ингибитора протеазы вируса гепатита с
RU2481340C2 (ru) *	2007-02-08	2013-05-10	Тиботек Фармасьютикалз Лтд.	Пиримидин-замещенные макроциклические ингибиторы hcv
ITMI20071616A1 (it)	2007-08-03	2009-02-04	Cosmo Spa	Processo enzimatico per l'ottenimento di 17-alfa monoesteri del cortexolone e/o suoi 9,11-deidroderivati.
CA2700383A1 (en) *	2007-09-24	2009-04-02	Achillion Pharmaceuticals, Inc.	Urea-containing peptides as inhibitors of viral replication
US8383583B2 (en)	2007-10-26	2013-02-26	Enanta Pharmaceuticals, Inc.	Macrocyclic, pyridazinone-containing hepatitis C serine protease inhibitors
US8426360B2 (en) *	2007-11-13	2013-04-23	Enanta Pharmaceuticals, Inc.	Carbocyclic oxime hepatitis C virus serine protease inhibitors
US8263549B2 (en)	2007-11-29	2012-09-11	Enanta Pharmaceuticals, Inc.	C5-substituted, proline-derived, macrocyclic hepatitis C serine protease inhibitors
US8202996B2 (en)	2007-12-21	2012-06-19	Bristol-Myers Squibb Company	Crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N- ((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamide
WO2009084695A1 (ja)	2007-12-28	2009-07-09	Carna Biosciences Inc.	２－アミノキナゾリン誘導体
CA2719008A1 (en)	2008-03-20	2009-09-24	Enanta Pharmaceuticals, Inc.	Fluorinated macrocyclic compounds as hepatitis c virus inhibitors
US8163921B2 (en)	2008-04-16	2012-04-24	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US7964560B2 (en)	2008-05-29	2011-06-21	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
CN102046648A (zh)	2008-05-29	2011-05-04	百时美施贵宝公司	丙型肝炎病毒抑制剂
US8207341B2 (en)	2008-09-04	2012-06-26	Bristol-Myers Squibb Company	Process or synthesizing substituted isoquinolines
UY32099A (es) *	2008-09-11	2010-04-30	Enanta Pharm Inc	Inhibidores macrocíclicos de serina proteasas de hepatitis c
US8044087B2 (en)	2008-09-29	2011-10-25	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US8563505B2 (en)	2008-09-29	2013-10-22	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
ES2527166T3 (es)	2008-12-10	2015-01-21	Achillion Pharmaceuticals, Inc.	Nuevos péptidos de 4-amino-4-oxobutanoílo como inhibidores de la replicación viral
US8283310B2 (en)	2008-12-15	2012-10-09	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
SMT201700121T1 (it)	2009-02-27	2017-03-08	Janssen Pharmaceuticals Inc	Sale amorfo di un inibitore macrociclico di hcv
TW201040181A (en)	2009-04-08	2010-11-16	Idenix Pharmaceuticals Inc	Macrocyclic serine protease inhibitors
US20120129875A1 (en) *	2009-05-29	2012-05-24	Syngenta Crop Protection, Llc	Substituted quinazolines as fungicides
AR077712A1 (es)	2009-08-05	2011-09-14	Idenix Pharmaceuticals Inc	Inhibidores de serina proteasa macrociclica
KR20140003521A (ko)	2010-12-30	2014-01-09	이난타 파마슈티칼스, 인코포레이티드	페난트리딘 매크로사이클릭 ｃ형 간염 세린 프로테아제 억제제
CN103534256B (zh)	2010-12-30	2016-08-10	益安药业	大环丙型肝炎丝氨酸蛋白酶抑制剂
TW201309690A (zh)	2011-02-10	2013-03-01	Idenix Pharmaceuticals Inc	巨環絲胺酸蛋白酶抑制劑，其醫藥組合物及其於治療ｈｃｖ感染之用途
US8957203B2 (en)	2011-05-05	2015-02-17	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US10201584B1 (en)	2011-05-17	2019-02-12	Abbvie Inc.	Compositions and methods for treating HCV
US8691757B2 (en)	2011-06-15	2014-04-08	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
MX340033B (es)	2011-12-28	2016-06-21	Janssen Sciences Ireland Uc	Derivados heterobiciclicos como inhibidores del virus de la hepatitis c.
MX348338B (es) *	2012-10-15	2017-06-07	Albemarle Corp	Procesos para la síntesis de 2-amino-4, 6-dimetoxibenzamida y otros compuestos de benzamida.
JP6154474B2 (ja)	2012-10-19	2017-06-28	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	Ｃ型肝炎ウイルス阻害剤
EP2914613B1 (de)	2012-11-02	2017-11-22	Bristol-Myers Squibb Company	Inhibitoren des hepatitis-c-virus
US9643999B2 (en)	2012-11-02	2017-05-09	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
WO2014071007A1 (en)	2012-11-02	2014-05-08	Bristol-Myers Squibb Company	Hepatitis c virus inhibitors
EP2914614B1 (de)	2012-11-05	2017-08-16	Bristol-Myers Squibb Company	Inhibitoren des hepatitis-c-virus
EP2964664B1 (de)	2013-03-07	2017-01-11	Bristol-Myers Squibb Company	Hemmer des hepatitis-c-virus
WO2014145600A1 (en)	2013-03-15	2014-09-18	Achillion Pharmaceuticals, Inc.	Ach-0142684 sodium salt polymorphs, composition including the same, and method of manufacture thereof
WO2014145507A1 (en)	2013-03-15	2014-09-18	Achillion Pharmaceuticals, Inc.	A process for making a 4-amino-4-oxobutanoyl peptide cyclic analogue, an inhibitor of viral replication, and intermediates thereof
WO2015103490A1 (en)	2014-01-03	2015-07-09	Abbvie, Inc.	Solid antiviral dosage forms
EP3108879A1 (de)	2015-06-25	2016-12-28	Cassiopea S.p.A.	Hochkonzentrierte formulierung

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6323180B1 (en)	1998-08-10	2001-11-27	Boehringer Ingelheim (Canada) Ltd	Hepatitis C inhibitor tri-peptides
UA74546C2 (en)	1999-04-06	2006-01-16	Boehringer Ingelheim Ca Ltd	Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition
US6867185B2 (en) *	2001-12-20	2005-03-15	Bristol-Myers Squibb Company	Inhibitors of hepatitis C virus
EP1497282A2 (de)	2002-04-11	2005-01-19	Vertex Pharmaceuticals Incorporated	Hemmer der serin-protease, besonders der ns3-ns4-protease des hepatitis-c-virus
MY140680A (en)	2002-05-20	2010-01-15	Bristol Myers Squibb Co	Hepatitis c virus inhibitors
US20050075279A1 (en) *	2002-10-25	2005-04-07	Boehringer Ingelheim International Gmbh	Macrocyclic peptides active against the hepatitis C virus
US20040180815A1 (en) *	2003-03-07	2004-09-16	Suanne Nakajima	Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors
CN1771050A (zh) *	2003-02-07	2006-05-10	益安药业	丙型肝炎丝氨酸蛋白酶的大环抑制剂
ATE422895T1 (de) *	2003-04-16	2009-03-15	Bristol Myers Squibb Co	Makrocyclische isochinolinpeptidinhibitoren des hepatitis-c-virus
US7125845B2 (en) *	2003-07-03	2006-10-24	Enanta Pharmaceuticals, Inc.	Aza-peptide macrocyclic hepatitis C serine protease inhibitors
EP1673385B1 (de) *	2003-09-22	2011-03-02	Boehringer Ingelheim International GmbH	Makrozyklische peptide mit wirkung gegen das hepatitis-c-virus
ES2336009T3 (es) *	2004-01-30	2010-04-07	Medivir Ab	Inhibidores de la ns-3 serina proteasa del vhc.
EP1910347A2 (de) *	2005-07-29	2008-04-16	Medivir Ab	Makrozyklische hepatitis-c-virus-inhibitoren
PE20070211A1 (es) *	2005-07-29	2007-05-12	Medivir Ab	Compuestos macrociclicos como inhibidores del virus de hepatitis c
EP1919904B1 (de) *	2005-07-29	2014-01-08	Janssen R&D Ireland	Makrozyklische hemmer des hepatitis-c-virus
AR055105A1 (es) *	2005-07-29	2007-08-08	Tibotec Pharm Ltd	Inhibidores macrociclicos del virus de la hepatitis c

2006
- 2006-07-26 PE PE2006000903A patent/PE20070343A1/es not_active Application Discontinuation
- 2006-07-28 NZ NZ564540A patent/NZ564540A/en not_active IP Right Cessation
- 2006-07-28 EP EP06764268A patent/EP1912981B1/de not_active Expired - Lifetime
- 2006-07-28 SI SI200630627T patent/SI1912981T1/sl unknown
- 2006-07-28 AU AU2006274866A patent/AU2006274866B2/en not_active Ceased
- 2006-07-28 AP AP2008004306A patent/AP2585A/xx active
- 2006-07-28 GT GT200600343A patent/GT200600343A/es unknown
- 2006-07-28 ES ES06764268T patent/ES2339702T3/es not_active Expired - Lifetime
- 2006-07-28 JP JP2008523383A patent/JP5230418B2/ja not_active Expired - Fee Related
- 2006-07-28 AT AT06764268T patent/ATE455775T1/de active
- 2006-07-28 KR KR1020087004894A patent/KR101083631B1/ko not_active Expired - Fee Related
- 2006-07-28 CA CA2617103A patent/CA2617103C/en not_active Expired - Fee Related
- 2006-07-28 HR HR20100209T patent/HRP20100209T1/hr unknown
- 2006-07-28 TW TW095127585A patent/TWI387597B/zh not_active IP Right Cessation
- 2006-07-28 WO PCT/EP2006/064822 patent/WO2007014927A2/en not_active Ceased
- 2006-07-28 DE DE602006011905T patent/DE602006011905D1/de not_active Expired - Lifetime
- 2006-07-28 ME MEP-2012-119A patent/ME01454B/me unknown
- 2006-07-28 US US11/995,900 patent/US7659245B2/en not_active Expired - Fee Related
- 2006-07-28 MY MYPI20063670 patent/MY151026A/en unknown
- 2006-07-28 UY UY29704A patent/UY29704A1/es unknown
- 2006-07-28 PT PT06764268T patent/PT1912981E/pt unknown
- 2006-07-28 RS RSP-2010/0183A patent/RS51227B/sr unknown
- 2006-07-28 AR ARP060103303A patent/AR057702A1/es not_active Application Discontinuation
- 2006-07-28 PL PL06764268T patent/PL1912981T3/pl unknown
- 2006-07-28 EA EA200800482A patent/EA014188B1/ru not_active IP Right Cessation
- 2006-07-28 BR BRPI0614153-6A patent/BRPI0614153A2/pt not_active Application Discontinuation
- 2006-07-28 DK DK06764268.6T patent/DK1912981T3/da active
- 2006-07-29 SV SV2006002641A patent/SV2008002641A/es unknown
2007
- 2007-12-20 IL IL188320A patent/IL188320A/en not_active IP Right Cessation
2008
- 2008-02-29 NO NO20081075A patent/NO20081075L/no not_active Application Discontinuation
2010
- 2010-04-20 CY CY20101100355T patent/CY1110008T1/el unknown

Also Published As

Publication number	Publication date
PE20070343A1 (es)	2007-05-12
PT1912981E (pt)	2010-04-16
ES2339702T3 (es)	2010-05-24
KR20080033475A (ko)	2008-04-16
PL1912981T3 (pl)	2010-07-30
ATE455775T1 (de)	2010-02-15
US20090118312A1 (en)	2009-05-07
GT200600343A (es)	2007-08-06
SV2008002641A (es)	2008-07-23
RS51227B (sr)	2010-12-31
JP2009502890A (ja)	2009-01-29
HK1116488A1 (en)	2008-12-24
US7659245B2 (en)	2010-02-09
DE602006011905D1 (de)	2010-03-11
AU2006274866A1 (en)	2007-02-08
EP1912981B1 (de)	2010-01-20
EA200800482A1 (ru)	2008-06-30
AU2006274866B2 (en)	2012-04-12
IL188320A (en)	2014-07-31
WO2007014927A2 (en)	2007-02-08
HRP20100209T1 (hr)	2010-05-31
CA2617103C (en)	2015-01-06
CA2617103A1 (en)	2007-02-08
JP5230418B2 (ja)	2013-07-10
TW200745116A (en)	2007-12-16
WO2007014927A3 (en)	2007-11-29
SI1912981T1 (sl)	2010-05-31
EA014188B1 (ru)	2010-10-29
TWI387597B (zh)	2013-03-01
DK1912981T3 (da)	2010-05-25
IL188320A0 (en)	2008-04-13
AR057702A1 (es)	2007-12-12
CY1110008T1 (el)	2015-01-14
MY151026A (en)	2014-03-31
EP1912981A2 (de)	2008-04-23
UY29704A1 (es)	2007-05-31
AP2585A (en)	2013-02-04
KR101083631B1 (ko)	2011-11-16
NZ564540A (en)	2010-03-26
ME01454B (me)	2014-04-20
BRPI0614153A2 (pt)	2011-03-15

Legal Events

Date	Code	Title	Description
2016-02-29	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
WO2007014927A3 (en)	2007-11-29	Macrocyclic inhibitors of hepatitis c virus
NO20080879L (no)	2008-04-17	HCV-NS3-proteaseinhibitorer
TW200745120A (en)	2007-12-16	Indolobenzazepine HCV NS5B inhibitors
EA200702493A1 (ru)	2008-04-28	Соединения и способы лечения или предотвращения флавивирусных инфекций
PE20090478A1 (es)	2009-05-24	Compuestos de indol macrociclicos como inhibidores de la proteasa del virus de la hepatitis c
HRP20090078A2 (en)	2009-06-30	Novel pyridazine compound and use thereof
CY1111423T1 (el)	2015-08-05	Αναστολεις ns5b hcv
MY140729A (en)	2010-01-15	Amide derivatives
WO2007103550A3 (en)	2007-11-08	Substituted aminothiazole derivatives with anti-hcv activity
PE20091381A1 (es)	2009-09-18	Inhibidores del virus de la hepatitis c
NO20085240L (no)	2009-03-30	C-fenyl-1-tioglucitolforbindelse
NO20073849L (no)	2007-10-10	Indolderivater for behandling av virale infeksjoner
NO20090270L (no)	2009-03-03	Cinnamoyl-piperazinederivater og deres anvendelse som PAR-I-antagonister
NO20075186L (no)	2008-02-14	Substituerte glycinamider som har antitrombotisk og faktor XA-inhiberende effekt.
DK1569929T3 (da)	2010-08-16	Forbindelser og fremgangsmåder til behandling eller forebyggelse af flavi-virusinfektioner
WO2011009084A3 (en)	2011-04-28	Benzimidazole analogues for the treatment or prevention of flavivirus infections
WO2010062821A8 (en)	2010-09-30	Anti-viral compounds, compositions, and methods of use
WO2010063996A3 (en)	2010-12-29	Antibacterial compounds
TW200732336A (en)	2007-09-01	Alyphactic heterocyclic compounds
NO20063407L (no)	2006-09-26	Benzenforbindelser disubstituert med cykliske grupper i 1- og 2-posisjoner
MY140868A (en)	2010-01-29	Amide derivatives
NO20076680L (no)	2008-04-30	Utvalgte CGRP-antagonister, metoder for fremstilling av disse og deres anvendelse som medikamenter
TW200640879A (en)	2006-12-01	Amide derivatives
NO20053570L (no)	2006-01-23	Termostabilt, vannopploselig polymer som er tverrbindbar ved hoye temperaturer
WO2008042497A3 (en)	2009-08-13	Benzoxazole and benzothiazole compounds useful as authentication compounds in polymer articles